Treatment options for recurrent glioblastoma: a network meta-analysis
- 13 April 2020
- journal article
- research article
- Published by Wiley in Emergencias
- Vol. 2020 (4)
- https://doi.org/10.1002/14651858.cd013579
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:Keywords
This publication has 24 references indexed in Scilit:
- Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survivalNeuro-Oncology Practice, 2019
- Anti-angiogenic therapy for high-grade gliomaEmergencias, 2018
- European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with gliomaThe Lancet Oncology, 2017
- GetReal in network meta‐analysis: a review of the methodologyResearch Synthesis Methods, 2016
- Visualizing Assumptions and Results in Network Meta-analysis: The Network Graphs PackageThe Stata Journal: Promoting communications on statistics and Stata, 2015
- Canadian Recommendations for the Treatment of Recurrent or Progressive Glioblastoma MultiformeCurrent Oncology, 2011
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade GliomaJournal of Clinical Oncology, 2010
- Supportive Care of Brain Tumor PatientsHematology/Oncology Clinics of North America, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta‐AnalysisPublished by Wiley ,2001